Skip to content

科品

US · KOPN #3394 按市值排名
3.29 -0.52 -13.53%
实时 - 追踪5344个代码 - 心跳于147秒前 · 2026-10-16 20:02

最新新闻

  • 公司公告
    SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
    SEC · 2024/11/14
  • Oppenheimer Initiates Kopin(KOPN.US) With Buy Rating, Announces Target Price $7
    \u5e02\u573a\u8d44\u8baf · 2026/9/17
  • 评级变动
    Analysts Offer Insights on Technology Companies: A10 Networks (ATEN), Gorilla Technology Group Inc. (GRRR) and Kopin (KOPN)
    TipRanks · 2026/9/15
  • 公司公告
    Phio Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
    SEC · 2024/11/14
  • 评级变动
    Lake Street Maintains Kopin(KOPN.US) With Buy Rating, Maintains Target Price $7
    \u5e02\u573a\u8d44\u8baf · 2026/9/15
  • Fabric.AI Files Two U.S. Patent Applications For Micro-LED Optical Interconnect Tech Co-Developed With Kopin; Expects Hardware Demo In January 2027
    Benzinga · 2026/9/23
  • 评级变动
    Craig-Hallum Maintains Kopin(KOPN.US) With Buy Rating, Maintains Target Price $10
    \u5e02\u573a\u8d44\u8baf · 2026/8/11
  • Stifel Maintains Kopin(KOPN.US) With Buy Rating, Maintains Target Price $6.5
    \u5e02\u573a\u8d44\u8baf · 2026/9/25
  • 评级变动
    Stifel Maintains Kopin(KOPN.US) With Buy Rating, Raises Target Price to $6.5
    \u5e02\u573a\u8d44\u8baf · 2026/5/13
  • 评级变动
    Lucid Capital Initiates Kopin(KOPN.US) With Buy Rating, Announces Target Price $10
    \u5e02\u573a\u8d44\u8baf · 2026/5/13
  • 评级变动
    CCORF Initiates Kopin(KOPN.US) With Buy Rating, Announces Target Price $6.25
    \u5e02\u573a\u8d44\u8baf · 2026/5/15
  • 公司公告
    PainReform | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.5%),Daniel B. Asher(4.5%), etc.
    SEC · 2024/11/14
  • 公司公告
    SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
    SEC · 2024/11/14
  • 评级变动
    CCORF Maintains Kopin(KOPN.US) With Buy Rating, Raises Target Price to $5.5
    \u5e02\u573a\u8d44\u8baf · 2026/5/9
  • 评级变动
    Craig-Hallum Maintains Kopin(KOPN.US) With Buy Rating, Announces Target Price $10
    \u5e02\u573a\u8d44\u8baf · 2026/5/13
  • Craig-Hallum Maintains Kopin(KOPN.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/9/18
  • 评级变动
    A Quick Look at Today's Ratings for Kopin(KOPN.US), With a Forecast Between $6.25 to $10
    \u5e02\u573a\u8d44\u8baf · 2026/5/14
  • Fabric.AI Files Two Patent Applications Covering Fiber-Coupled and Connector-Free MicroLED Optical Interconnect, Developed With Kopin
    GlobeNewswire · 2026/9/23
  • 公司公告
    PharmaCyte Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%), etc.
    SEC · 2024/11/14
  • 评级变动
    CCORF Maintains Kopin(KOPN.US) With Buy Rating, Raises Target Price to $6.5
    \u5e02\u573a\u8d44\u8baf · 2026/8/20

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 20:02:12 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

科品 讨论区 0 条评论

发表评论